Current Opinion in Virology

Papers
(The median citation count of Current Opinion in Virology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Structure of SARS-CoV-2 spike protein135
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19123
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection102
Recent advances in antiviral drug development towards dengue virus76
Future considerations for the mRNA-lipid nanoparticle vaccine platform64
Current challenges to virus discovery by meta-transcriptomics62
Zoonotic disease and virome diversity in bats59
Global overview and major challenges of host prediction methods for uncultivated phages57
Animal models for SARS-CoV-254
Structure and function of SARS-CoV-2 polymerase54
The virome of vector mosquitoes53
Coronavirus entry: how we arrived at SARS-CoV-253
Dengue vaccine development by the year 2020: challenges and prospects50
A structural view of the SARS-CoV-2 virus and its assembly50
A new generation of vaccines based on alphavirus self-amplifying RNA49
The healthy human virome: from virus–host symbiosis to disease48
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing46
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus45
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses43
Engineering therapeutic phages for enhanced antibacterial efficacy42
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi41
Viral Z-RNA triggers ZBP1-dependent cell death40
COVID-19, the first pandemic in the post-genomic era39
Structure, function and assembly of the long, flexible tail of siphophages39
European regulatory aspects of phage therapy: magistral phage preparations37
Host cell-intrinsic innate immune recognition of SARS-CoV-237
Influenza D virus35
Anti-viral protective capacity of tissue resident memory T cells34
Dengue mouse models for evaluating pathogenesis and countermeasures34
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?34
Entry of influenza A virus into host cells — recent progress and remaining challenges34
Perspective on taxonomic classification of uncultivated viruses34
Risk factors and biomarkers of severe dengue33
Tombusviruses orchestrate the host endomembrane system to create elaborate membranous replication organelles31
Mitigation of evolved bacterial resistance to phage therapy31
Detection of viruses by inflammasomes30
Adenovirus – a blueprint for gene delivery29
Rotavirus cell entry: not so simple after all29
Viral structural proteins as targets for antivirals29
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy28
Drug resistance mutations in HIV: new bioinformatics approaches and challenges28
Current view and perspectives in viroid replication28
Animal models of SARS-CoV-2 transmission27
Extracellular vesicles in virus infection and pathogenesis26
Epigenetic control of the Epstein-Barr lifecycle26
Natural killer cells and unconventional T cells in COVID-1926
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world26
Hepatitis B virus–host interactions and novel targets for viral cure26
Cytomegalovirus as an immunomodulator across the lifespan25
Progress and pitfalls of a year of drug repurposing screens against COVID-1925
Immune system control of hepatitis C virus infection25
Digital phagograms: predicting phage infectivity through a multilayer machine learning approach24
Development of plant-made monoclonal antibodies against viral infections22
R gene mediated defense against viruses22
Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV00522
The long and winding road: human papillomavirus entry and subcellular trafficking22
Mapping the diverse structural landscape of the flavivirus antibody repertoire22
Proteases and variants: context matters for SARS-CoV-2 entry assays22
Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone21
An overview of the current state of phage therapy for the treatment of biofilm-related infections21
Tissues: the unexplored frontier of antibody mediated immunity21
Targeting of viral RNAs by Upf1-mediated RNA decay pathways21
Measles immunity and immunosuppression21
The gut virome in inflammatory bowel diseases21
Molecular dynamics of the viral life cycle: progress and prospects21
UPR signaling at the nexus of plant viral, bacterial, and fungal defenses20
Phage therapy for secondary bacterial infections with COVID-1920
Assembly of the virome in newborn human infants20
Shopping for phages? Unpacking design rules for therapeutic phage cocktails19
Revisiting an old friend: new findings in alphavirus structure and assembly19
Virus genomics: what is being overlooked?19
Remdesivir for the treatment of Covid-19: the value of biochemical studies19
Evolution of the interferon response: lessons from ISGs of diverse mammals18
Broadly neutralizing antibodies against HIV-1 and concepts for application18
Rhabdoviruses as vectors for vaccines and therapeutics18
Dengue virus infection and Nrf2 regulation of oxidative stress18
Antiviral immunity triggered by infection-induced host transposable elements18
Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis18
Unresolved questions in the zoonotic transmission of MERS18
Advances in human monoclonal antibody therapy for HBV infection17
The enigmatic roles of Anelloviridae and Redondoviridae in humans17
Endocytosis of Bacteriophages17
Structures of the tailed bacteriophages that infect Gram-positive bacteria16
Cryo-electron microscopy of nodavirus RNA replication organelles illuminates positive-strand RNA virus genome replication16
The origin of Human Papillomavirus (HPV) — induced cervical squamous cancer16
The influence of microbiota-derived metabolites on viral infections16
Bat virome research: the past, the present and the future16
The remarkable viral portal vertex: structure and a plausible model for mechanism15
Innate immunity and HBV persistence15
The surface glycoproteins of hantaviruses15
Antigenic evolution of SARS coronavirus 215
Emerging technologies in the study of the virome15
Progress and prospects of the healthy human gut virome14
Fighting viruses with computers, right now14
Immunotherapy and therapeutic vaccines for chronic HBV infection14
Immune–bacteriophage interactions in inflammatory bowel diseases14
Microbiota as a potentially-modifiable factor influencing COVID-1914
Virus–host protein interactions as footprints of human cytomegalovirus replication14
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification14
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-213
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination13
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?13
Broadly neutralizing antibodies against COVID-1913
Seeing and touching adenovirus: complementary approaches for understanding assembly and disassembly of a complex virion13
Flavivirus nonstructural proteins and replication complexes as antiviral drug targets13
Virion structures and genome delivery of honeybee viruses13
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance12
Hepatitis B virus e antigen and viral persistence12
Mutational escape from cellular immunity in viral hepatitis: variations on a theme12
Cytotoxicity in Epstein Barr virus specific immune control12
HIV persistence: silence or resistance?12
SARS-CoV-2 vaccines — the biggest medical research project of the 21st century12
Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-112
Arms race between rice and viruses: a review of viral and host factors11
Natural killer cell responses to emerging viruses of zoonotic origin11
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs11
SnRK1: a versatile plant protein kinase that limits geminivirus infection11
Quantitative measures of within-host viral genetic diversity11
The morphogenesis of different giant viruses as additional evidence for a common origin of Nucleocytoviricota10
Co-opted membranes, lipids, and host proteins: what have we learned from tombusviruses?10
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?10
T cell responses during HBV and HCV infections: similar but not quite the same?10
Hepatitis C virus and intracellular antiviral response10
Potential of plasmid only based reverse genetics of rotavirus for the development of next-generation vaccines10
Structural perspectives on HCV humoral immune evasion mechanisms10
Platelets in the pathogenesis of flavivirus disease10
Structural and dynamic asymmetry in icosahedrally symmetric virus capsids10
Fishing for phages in metagenomes: what do we catch, what do we miss?10
Tools for the targeted genetic modification of poxvirus genomes9
Mapping conformational epitopes by NMR spectroscopy9
The journey of herpesvirus capsids and genomes to the host cell nucleus9
Broad neutralizing antibody-based strategies to tackle influenza9
Immunity to acute virus infections with advanced age9
Understanding T cell aging to improve anti-viral immunity9
Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design9
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-29
Reverse genetics approaches for live-attenuated vaccine development of infectious bursal disease virus9
Plant negative-stranded RNA virus biology and host interactions revitalized by reverse genetics9
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease9
Flavivirus–host interactions: an expanding network of proviral and antiviral factors9
Host defence and persistent human papillomavirus infection9
Non-structural protein 5 (NS5) as a target for antiviral development against established and emergent flaviviruses9
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 18
Highly efficient vaccines for Bluetongue virus and a related Orbivirus based on reverse genetics8
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success8
Reverse genetics approaches for hepatitis E virus and related viruses8
The importance of viral and cellular factors on flavivirus entry8
Virus structure and structure-based antivirals8
Recent progress in development of monoclonal antibodies against human cytomegalovirus8
Microbiota-immune system interactions and enteric virus infection8
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response8
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells8
Gut microbiota in the innate immunity against hepatitis B virus — implication in age-dependent HBV clearance8
The road to effective and accessible antibody therapies against Ebola virus8
Reverse genetics approaches for the development of bunyavirus vaccines8
HIV-1 entry: Duels between Env and host antiviral transmembrane proteins on the surface of virus particles8
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications8
Alohomora! What the entry mechanisms tell us about the evolution and diversification of giant viruses and their hosts8
Entry of hepatitis B virus: going beyond NTCP to the nucleus8
Know your enemy and know yourself – the case of SARS-CoV-2 host factors8
Structure and physiology of giant DNA viruses8
0.023555040359497